Viewing Study NCT00899093


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2025-12-26 @ 1:40 PM
Study NCT ID: NCT00899093
Status: TERMINATED
Last Update Posted: 2018-05-22
First Post: 2009-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
Sponsor: Gynecologic Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module